Improvement of Quality of Life after Surgical Treatment of Patients with MRONJ: A Prospective Analysis Using the SF‐12 and OHIP‐14 Questionnaires
Open Access
- 1 January 2024
- journal article
- research article
- Published by Wiley in International Journal of Dentistry
- Vol. 2024 (1) , 4435791
Abstract
Background. Medication‐related osteonecrosis of the jaw (MRONJ) is a rare, serious, and debilitating disease of unknown cause that can be associated with significant health‐related quality of life (HRQOL) impairment. Hematological disease is characterized by a nonhealing exposed jawbone in patients with a history of antiresorptive or antiangiogenic agent use without radiation exposure to the head or neck. Patients and Materials and Methods. This prospective study over the period from May 2020 to December 2021 included a representative sample consisting of 27 patients with at least stage 2 MRONJ lesions who underwent surgical rehabilitation via oral and maxillofacial surgery at the University Medical Center Göttingen, Germany. Quality of life data were collected over a 6‐month postoperative period using the Health‐Related QOL (SF‐12) and Oral Health‐Related QOL (OHIP‐14) questionnaires. Results. A total of 27 patients considered in the study had a total of 42 MRONJ lesions, corresponding to a mean of 1.56 necroses per patient. MRONJ lesions were downstaged in 85% of the patients. HRQOL was evaluated with the SF‐12 questionnaire. Significant improvements were found in six of the eight categories (General Health (p < 0.001), Bodily Pain (p < 0.001), Mental Health (p < 0.001), Vitality (p < 0.001), Role‐Emotional (p = 0.028), and Social Functioning (p = 0.031)). The OHRQOL score also improved significantly after surgical intervention (p < 0.001). Conclusion. With completed surgical therapy, improvements in HRQOL and OHRQOL are measurable.Keywords
Funding Information
- Goettingen University
This publication has 32 references indexed in Scilit:
- Quality of life in cancer patients with or without medication-related osteonecrosis of the jawSupportive Care in Cancer, 2021
- Patients’ quality of life improves after surgical intervention of stage III medication-related osteonecrosis of the jawOral and Maxillofacial Surgery, 2020
- Which symptoms negatively affect the oral health–related quality of life in patients with osteonecrosis of the jaw?Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2020
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 UpdateJournal of Oral and Maxillofacial Surgery, 2014
- Ostéonécroses des maxillaires dues aux bisphosphonates administrés par voie intraveineuse : incidence et facteurs de risqueMédecine Buccale Chirurgie Buccale, 2013
- Application of the Oral Health Impact Profile (OHIP) among Taiwanese elderlyQuality of Life Research, 2011
- Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-upSupportive Care in Cancer, 2009
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 UpdateJournal of Oral and Maxillofacial Surgery, 2009
- The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the JawsJournal of Oral and Maxillofacial Surgery, 2009
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004